James Garner AKA JG, page-2

He's been given a big wrap by our Chair so I figure we have to trust the board has done their homework and JG is fit for purpose and delivers the goods for ANP!

This excerpt from an article in May this year -

"Dr. Garner has significant experience in drug development and commercialisation, acquired through regional and global roles in the biotechnology and pharmaceutical sectors. He has served in roles with Biogen, Progen Pharmaceuticals, Quintiles, and Sanofi. Most recently, he was CEO of the clinical-stage oncology company Kazia Therapeutics.
"I am delighted that the robust and competitive process culminated in a leader of James’s calibre and in-depth skill set,” said Antisense Dr. Gittleson.
“As we look to the future, the Board is confident James will leverage our momentum from the Phase IIb clinical study, and other ongoing activities, to enhance the Company’s position and create significant value for shareholders and all stakeholders. We look forward to working with him.”
“I am delighted to join Antisense at this very important point in the Company’s development,” said Dr Garner.
“We enjoy an exciting pipeline, an excellent team, and world-class scientific collaborators. There is a profound unmet need for new treatment options in Duchenne Muscular Dystrophy (DMD), and I look forward to working with the Board and the team to bring ATL1102 forward for children and their families who are affected by this devastating disease.”
Dr. Gittleson added, "We are proud of the journey we have taken as a company with Mark, from the initial licensing of a promising molecule to now reaching the exciting milestone of re-entering the clinic in DMD. Our Phase IIb trial in Europe, coupled with the progress we are making in the US, is a testament to the dedication of our team, and we look forward to bringing this potentially life-changing therapy to patients in need"

Let's cut him some slack in the interim and let him settle into his new role as CEO - I say good luck for next week JG and wish him a successful tenure

Cheers